SLDB Company Profile and Key Details

Q: Who are the executives of SLDB?

Mr. Ilan GanotCo-founder, Strategic Advisor to the Chief Executive Officer & DirectorMr. Gilad David HayeemCo-FounderMr. Stephen J. Di Palma M.B.A, M.B.A.ConsultantMr. David Tyronne Howton Jr., J.D.Chief Admin. Officer & Sec.Ms. Erin Powers BrennanChief Legal Officer & Sec.Mr. Paul HerzichChief Technology OfficerDr. Carl Ashley Morris Ph.D.Chief Scientific Officer of NeuromuscularMr. Ian F. Smith A.C.A., ACA, C.P.A., CPAExecutive ChairMr. Alexander G. CumboPres, Chief Executive Officer & DirectorMr. Matthew Bennett ArnoldCo-Founder & Board MemberMs. Annie GanotCo-Founder & Head of Patient AdvocacyDr. Andrey Juan Zarur Ph.D.Co-FounderMr. Kevin Tan C.F.A.Chief Financial Officer & Treasurer

NASDAQ : SLDB

Solid Biosciences

$7.97

0.08+1.01%

At Close 4:00 PM

63.06

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Solid Biosciences Inc. (SLDB) stock surged +1.01%, trading at $7.97 on NASDAQ, up from the previous close of $7.89. The stock opened at $7.88, fluctuating between $7.65 and $8.04 in the recent session.

Stock Snapshot

7.89

Prev. Close

784.64M

Market Cap

7.65

Day Low

-4.15

P/E Ratio

-1.92

EPS (TTM)

-4.69

Cash Flow per Share

7.88

Open

98.45M

Number of Shares

8.035

Day High

74.92%

Free Float in %

6.2

Book Value

1.23M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 28, 2026	7.88	8.04	7.65	7.97	1.23M
Jul 27, 2026	8.01	8.41	7.87	7.89	1.22M
Jul 24, 2026	8.07	8.09	7.70	7.83	1.09M
Jul 23, 2026	8.00	8.14	7.80	7.98	956.13K
Jul 22, 2026	8.39	8.43	8.07	8.10	963.56K
Jul 21, 2026	8.43	8.58	8.27	8.46	989.85K
Jul 20, 2026	8.78	9.01	8.41	8.45	1M
Jul 17, 2026	8.78	9.03	8.62	8.72	1.49M
Jul 16, 2026	9.42	9.45	8.87	9.05	1.01M
Jul 15, 2026	9.59	9.79	9.34	9.62	951.06K
Jul 14, 2026	9.79	9.94	9.61	9.63	907.93K
Jul 13, 2026	10.19	10.25	9.46	9.72	1.19M
Jul 10, 2026	11.11	11.11	9.91	10.42	1.47M
Jul 09, 2026	10.97	11.17	10.89	11.14	1.02M
Jul 08, 2026	10.86	11.34	10.63	11.00	1.33M
Jul 07, 2026	11.07	11.33	10.54	11.15	1.42M
Jul 06, 2026	10.81	11.45	10.70	11.07	2.85M
Jul 02, 2026	10.38	10.88	10.24	10.84	2.63M
Jul 01, 2026	10.04	10.21	9.76	10.20	2.03M
Jun 30, 2026	9.50	10.41	9.38	9.99	2.37M

Contact Details

Charlestown, MA 02139

United States

https://www.solidbio.com 617 337 4680

About Company

Solid Biosciences Inc. is an American biotechnology firm dedicated to creating therapeutic solutions for Duchenne Muscular Dystrophy (DMD). Its most advanced experimental drug, SGT-001, is a gene transfer treatment currently in Phase I/II clinical trials, designed to encourage the production of functional dystrophin protein in patients' muscles. The company is also progressing with SGT-003, which represents a next-generation gene transfer therapy intended for DMD. Beyond specific drug candidates, Solid Biosciences is actively developing innovative platform technologies, such as "dual gene expression," a technique that allows for multiple therapeutic genes to be bundled into a single viral vector, and researching new capsid designs. The company maintains a strategic alliance through a collaboration and license agreement with Ultragenyx Pharmaceutical Inc., focusing on the joint development and market introduction of novel gene therapies for Duchenne Muscular Dystrophy. Founded in 2013, Solid Biosciences Inc. conducts its operations from its headquarters in Cambridge, Massachusetts.

Stock Peers

ARGX

-16.59-1.87%

argenx SE$872.23 REGN

28.01+4.20%

Regeneron Pharmaceuticals, Inc.$695.18 MDGL

-12.45-2.26%

Madrigal Pharmaceuticals, Inc.$538.80 UTHR

-4.31-0.82%

United Therapeutics Corporation$523.63 VRTX

11.39+2.38%

Vertex Pharmaceuticals Incorporated$490.39 KRYS

12.41+3.53%

Krystal Biotech, Inc.$364.23 ONC

4.56+1.40%

BeOne Medicines AG$330.46 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

-1.22-0.41%

Ligand Pharmaceuticals Incorporated$296.28 PRAX

-19.99-6.33%

Praxis Precision Medicines, Inc.$295.81

Frequently Asked Questions

What is the current Solid Biosciences Inc. (SLDB) stock price?

Solid Biosciences Inc. (NASDAQ: SLDB) stock price is $7.97 in the last trading session. During the trading session, SLDB stock reached the peak price of $8.04 while $7.65 was the lowest point it dropped to. The percentage change in SLDB stock occurred in the recent session was 1.01% while the dollar amount for the price change in SLDB stock was $0.08.

SLDB's industry and sector of operation?

The NASDAQ listed SLDB is part of Biotechnology industry that operates in the broader Healthcare sector. Solid Biosciences Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of SLDB?

Mr. Ilan Ganot
Co-founder, Strategic Advisor to the Chief Executive Officer & Director
Mr. Gilad David Hayeem
Co-Founder
Mr. Stephen J. Di Palma M.B.A, M.B.A.
Consultant
Mr. David Tyronne Howton Jr., J.D.
Chief Admin. Officer & Sec.
Ms. Erin Powers Brennan
Chief Legal Officer & Sec.
Mr. Paul Herzich
Chief Technology Officer
Dr. Carl Ashley Morris Ph.D.
Chief Scientific Officer of Neuromuscular
Mr. Ian F. Smith A.C.A., ACA, C.P.A., CPA
Executive Chair
Mr. Alexander G. Cumbo
Pres, Chief Executive Officer & Director
Mr. Matthew Bennett Arnold
Co-Founder & Board Member
Ms. Annie Ganot
Co-Founder & Head of Patient Advocacy
Dr. Andrey Juan Zarur Ph.D.
Co-Founder
Mr. Kevin Tan C.F.A.
Chief Financial Officer & Treasurer

How SLDB did perform over past 52-week?

SLDB's closing price is 110.29% higher than its 52-week low of $3.79 where as its distance from 52-week high of $11.45 is -30.39%.

How many employees does SLDB have?

Number of SLDB employees currently stands at 121.

Link for SLDB official website?

Official Website of SLDB is: https://www.solidbio.com

How do I contact SLDB?

SLDB could be contacted at phone 617 337 4680 and can also be accessed through its website. SLDB operates from 500 Rutherford Avenue, Charlestown, MA 02139, United States.

How many shares of SLDB are traded daily?

SLDB stock volume for the day was 1.23M shares. The average number of SLDB shares traded daily for last 3 months was 1.73M.

What is the market cap of SLDB currently?

The market value of SLDB currently stands at $784.64M with its latest stock price at $7.97 and 98.45M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	121
Beta	2.36
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	121
Beta	2.36
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

SLDB Company Profile and Key Details

Solid Biosciences

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Company Overview

Technical Performance

Dividend & Fair Value

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Earnings & Analyst Outlook

Valuation Metrics

Key Takeaways

Price Forecast & Outlook